BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 4088478)

  • 1. [Clinical evaluation of the activity of buflomedil in ischemic processes in the legs].
    Savagnone E; Sunseri V
    Minerva Cardioangiol; 1985 Nov; 33(11):757-64. PubMed ID: 4088478
    [No Abstract]   [Full Text] [Related]  

  • 2. [Digital blood flow in peripheral vascular diseases. Action of drugs: buflomedil].
    Frausini G; Rotatori P; Gaggi S; Barone A; Pupita F
    Minerva Cardioangiol; 1988 Jun; 36(6):319-22. PubMed ID: 3211330
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical experience and instrumental evaluation of buflomedil hydrochloride in the therapy of chronic obliterative arteriopathies of the legs].
    Lucisano V; Margheriti R; Matone P; Morrieri C; Rugolo A; Corsi V
    Clin Ter; 1986 Jun; 117(6):499-509. PubMed ID: 3527536
    [No Abstract]   [Full Text] [Related]  

  • 4. [Retrograde venous perfusion in treatment of diabetic gangrene].
    Nilius J; von Bary S
    Vasa Suppl; 1991; 32():420-1. PubMed ID: 1771548
    [No Abstract]   [Full Text] [Related]  

  • 5. [Vascular and hemorheologic effects of buflomedil chlorhydrate in chronic obliterative arteriopathies of the legs].
    Coglitore S; Manganaro A; Barbera MC; Cento D; Buda D; Arrigo F; Consolo F
    Minerva Cardioangiol; 1986 Nov; 34(11):745-9. PubMed ID: 2949163
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effects of buflomedil on peripheral arteriopathies. An open clinical study].
    Longo FN; Potortì F; Urbano O; Perroni GB
    Minerva Cardioangiol; 1988 May; 36(5):249-52. PubMed ID: 3059229
    [No Abstract]   [Full Text] [Related]  

  • 7. [Buflomedil chlorhydrate in peripheral vasculopathies].
    Dall'Antonia F; Perbellini A; Adami CA; Dal Cortivo G; Bucci S
    Clin Ter; 1986 Dec; 119(5):379-85. PubMed ID: 2951055
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of buflomedil on microcirculation of the skin in acral gangrene].
    Fagrell B; Hermansson IL
    Fortschr Med; 1985 Jan; 103(1-2):23-7. PubMed ID: 3882535
    [No Abstract]   [Full Text] [Related]  

  • 9. Buflomedil: potential new indications for an old agent.
    Tsantilas D; Hatzitolios AI; Tziomalos K; Papadimitriou DK
    Int Angiol; 2009 Jun; 28(3):170-4. PubMed ID: 19174750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Doppler flowmeter evaluation of the effects of the administration of buflomedil (irrodan) on peripheral circulation in patients with obstructive chronic arteriopathy].
    Abate S; Ferulano GP; Vanni L; Dilillo S; Picilli M; D'Alessio E
    Minerva Cardioangiol; 1985 Nov; 33(11):749-56. PubMed ID: 2935748
    [No Abstract]   [Full Text] [Related]  

  • 11. [The treatment of diabetic arteritis of the lower limbs by Trivastal].
    Journ Annu Diabetol Hotel Dieu; 1972; 13(0):326-31. PubMed ID: 4679620
    [No Abstract]   [Full Text] [Related]  

  • 12. [Usefulness of vasodilator agents Cavinton and Halidor in circulatory insufficiency of the lower limbs].
    Jonderko G; Szramek-Urbaniak A; Bednarczyk-Kałuzna M
    Przegl Lek; 1982; 39(9):617-20. PubMed ID: 7178532
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effects of the administration of buflomedil-hydrochloride on the arterial circulation of the legs in patients with obliterative arteriopathies].
    Tallarida G; Baldoni F; Peruzzi G; Raimondi G; Grimaldi I; Visigalli G; Gristina S; Massaro M; De Martinis L; Sangiorgi M
    Cardiologia; 1983 Aug; 28(8):651-60. PubMed ID: 6687209
    [No Abstract]   [Full Text] [Related]  

  • 14. [Buflomedil chlorhydrate in the treatment of retinopathies].
    Spallone A; Porta E; Bertazzi E; Ridling P; Ortolina S; Fatigati G; Carlevaro G; Visentin E; Capilli G
    Clin Ter; 1987 Apr; 121(2):125-8. PubMed ID: 2956000
    [No Abstract]   [Full Text] [Related]  

  • 15. Experience with buflomedil in peripheral arterial occlusive disease.
    Balas P; Pagratis N
    Angiology; 1981 Oct; 32(10):679-85. PubMed ID: 7325404
    [No Abstract]   [Full Text] [Related]  

  • 16. [Ozone therapy, a new method of treating chronic obliterating arteriopathies].
    Ionescu G; Pitea P; Blaj A
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1985; 34(3):207-13. PubMed ID: 2931752
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical experience with a new peripheral vasodilator agent, in which are combined raubasine, and 2 ergot alkaloids in the treatment of peripheral diabetic angiopathy].
    Martínez-López JM; Calvo-Fernández R; Garrido-Toro A; Sánchez-Cañaveral F
    Angiologia; 1973; 25(4):195-8. PubMed ID: 4717702
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of circulatory insufficiency with buflomedil chlorhydrate in chronic hemodialysis patients].
    Montemurro NE; Damiano M
    Clin Ter; 1986 Mar; 116(6):485-9. PubMed ID: 3720235
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative study of various schedules of buflomedil treatment in peripheral arterial insufficiency of the lower limbs. Evaluation of its therapeutic efficacy].
    Paoletti V; Mammarella A; Alessandrini A; Barlattani M
    Clin Ter; 1984 Jul; 110(1):29-36. PubMed ID: 6237843
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of buflomedil hydrochloride in ocular pathology].
    Campinchi R; Schmitt A
    Bull Soc Ophtalmol Fr; 1981; 81(4-5):413-4. PubMed ID: 7261227
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.